每年專案
個人檔案
學歷
- 2009 臺北醫學大學醫學研究所博士
- 1985-1992 國立台灣大學醫學系學士
經歷
- 2023.04- 臺北醫學大學附設醫院醫務副院長
- 2021.08-2023.04 臺北醫學大學附設醫院副院長
- 2017.08- 臺北醫學大學細胞治療與再生醫學國際博士學位教授
- 2015.08- 臺北醫學大學臨床藥物基因體學暨蛋白質體學碩副教授
- 2015.08- 臺北醫學大學醫學系外科學科教授
- 2021.08-2023.08 臺北醫學大學附設醫院醫療品質部主任
- 2020.11-2021.07 臺北醫學大學附設醫院核子醫學科主任
- 2019.01-2021.07 臺北醫學大學附設醫院醫務副院長
- 2016.06-2017.07 臺北醫學大學醫學系副主任
- 2016 臺北醫學大學附設醫院教學副院長
- 2015 臺北醫學大學附設醫院外科部副部長
- 2015.08-2016.07 臺北醫學大學附設醫院醫療品質部主任
- 2014.08- 臺北醫學大學臨床醫學研究所
- 2014.02- 臺北醫學大學癌症生物學與藥物研發博士學位學程
- 2012.08-2015.07 臺北醫學大學醫學系外科學科副教授
- 2009.08-2012.07 臺北醫學大學醫學系外科學科助理教授
- 2006.02-2009.07 臺北醫學大學醫學系外科學科講師
- 2008 臺北醫學大學附設醫院一般外科主任
- 臺北醫學大學附設醫院外科主治醫師
- 2005.12-2006.05 敏盛醫院直腸外科主任
- 2004.07-2005.11 恩主公醫院一般外科主任
- 2003.07-2004.06 恩主公醫院直腸外科主任
- 1997.07-2003.06 恩主公醫院外科主治醫師
- 1992.07-1997.06 臺大醫院外科住院醫師
獎項
- 2015 104年度臺北醫學大學師鐸獎
- 2015 104年度臺北醫學大學優良教師獎
- 2013 102年度臺北醫學大學優良教師獎
- 2011 國際外科學會(ICS)優秀論文獎
研究興趣
- 癌症分子生物學
- 訊號傳遞
- 內質網壓力及轉移
- 大腸直腸手術
相關連結
指紋
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
-
In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer
Lee, C-C., Lee, A-W., Wei, P-L., Liu, Y-S., Chang, Y-J. & Huang, C-Y., 2023, 於: Scientific Reports. 13, 1研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53
Wang, W. L., Batzorig, U., Hung, C. S., Wei, P. L., Huang, C. Y. & Chang, Y. J., 2022, 於: BioMed Research International. 2022, 1322788.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取2 引文 斯高帕斯(Scopus) -
Cigarette Smoking Associated with Colorectal Cancer Survival: A Nationwide, Population-Based Cohort Study
Huang, Y. M., Wei, P. L., Ho, C. H. & Yeh, C. C., 2月 2 2022, 於: Journal of Clinical Medicine. 11, 4, 913.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取4 引文 斯高帕斯(Scopus) -
Clinical assessment for non-reversal stoma and stoma re-creation after reversal surgery for rectal cancer patients after sphincter-saving operation
Kuo, C. Y., Lin, Y. K., Wei, P. L., Chi-Yong Ngu, J., Lee, K. D., Chen, C. L., Huang, Y., Chen, C. C. & Kuo, L. J., 2022, (接受/付印) 於: Asian Journal of Surgery.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Clinical Safety and Effectiveness of Robotic-Assisted Surgery in Patients with Rectal Cancer: Real-World Experience over 8 Years of Multiple Institutions with High-Volume Robotic-Assisted Surgery
Huang, C. W., Wei, P. L., Chen, C. C., Kuo, L. J. & Wang, J. Y., 9月 2022, 於: Cancers. 14, 17, 4175.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取4 引文 斯高帕斯(Scopus)
資料集
-
Additional file 2: Figure S1. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huynh, T. (Contributor), Tzeng, Y. (Contributor), Yen, Y. (Creator), Yang, C. (Contributor), Wu, A. T. (Creator), Meng, T. (Contributor), Whang-Peng, J. (Creator), Wei, P. (Contributor), Hsiao, M. (Creator) & Huang, Y. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3704533_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3704533_d1.v1
資料集: Dataset
-
Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial
Yeh, Y. (Contributor), Tsai, H. (Contributor), Huang, C. (Creator), Wei, P. (Contributor), Sung, Y. (Contributor), Tang, H. (Contributor) & Wang, J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3751544.v1, https://doi.org/10.6084%2Fm9.figshare.c.3751544.v1
資料集: Dataset
-
Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huang, Y. (Contributor), Yang, C. (Contributor), Wei, P. (Contributor), Huynh, T. (Contributor), Whang-Peng, J. (Creator), Meng, T. (Contributor), Hsiao, M. (Creator), Tzeng, Y. (Contributor), Wu, A. T. (Creator) & Yen, Y. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3704533.v1, https://doi.org/10.6084%2Fm9.figshare.c.3704533.v1
資料集: Dataset
-
Additional file 1: of Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial
Tsai, H. (Contributor), Sung, Y. (Contributor), Tang, H. (Contributor), Yeh, Y. (Contributor), Wei, P. (Contributor), Wang, J. (Contributor) & Huang, C. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3751544_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3751544_d1.v1
資料集: Dataset
-
Additional file 2 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
Huang, H. (Contributor), HuangFu, W. (Creator), Cheng, Y. (Creator), Cheng, C. (Creator), Chang, F. (Creator), Sung, T. (Creator), Pan, S. (Creator), Lee, Y. (Contributor), Wei, P. (Contributor) & Huang, C. (Contributor), Figshare, 2021
DOI: 10.6084/m9.figshare.14228281.v1, https://doi.org/10.6084%2Fm9.figshare.14228281.v1
資料集: Dataset